The role of stent-grafts for prevention and treatment of restenosis

Journal of Cardiovascular Surgery

Volumn 51, Issue 4, 2010, Pages 579-589

  Kwa, A T ^a   Yeo, K K ^a   Laird, J R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary restenosis; Femoral artery; Thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; D DIMER;

CLINICAL EFFECTIVENESS; ENDOPROSTHESIS; FOOD AND DRUG ADMINISTRATION; GRAFT FAILURE; HUMAN; ILIAC ARTERY; IN-STENT RESTENOSIS; LIMB ISCHEMIA; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; REVIEW; SAFETY; STENT; STENT THROMBOSIS; SUPERFICIAL FEMORAL ARTERY;

ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONSTRICTION, PATHOLOGIC; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; PATIENT SELECTION; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RECURRENCE; RISK ASSESSMENT; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 78649241789     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Maynar M, Reyes R, Ferrai H, Gorriz E, Gomez-Toledo F, de Blas M et al. Cragg Endopro System I: early experience. I. Femoral arteries. J Vasc Interv Radiol 1997;8:203-7.
2. Ahmadi R, Schillinger M, Maca T, Minar E. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 2002;223:345-50.
3. Palmaz JC. Review of polymeric graft materials for endovascular applications. J Vasc Interv Radiol 1998;9(1 Pt 1):7-13.
4. Link J, Muller-Hulsbeck S, Brossmann J, Steffens JC, Heller M. Perivascular inflammatory reaction after percutaneous placement of covered stents. Cardiovasc Intervent Radiol 1996;19:345-7.
5. Marin ML, Veith FJ, Cynamon J, Sanchez LA, Bakal CW, Suggs WD et al. Human transluminally placed endovascular stented grafts: preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J Vasc Surg 1995;21:595-603; discussion 603-4.
6. van Sambeek MR, Hagenaars T, Gussenhoven EJ, Leertouwer TC, van der Lugt A, Hoedt MT et al. Vascular response in the femoropopliteal segment after implantation of an ePTFE balloon-expandable endovascular graft: an intravascular ultrasound study. J Endovasc Ther 2000;7:204-12.
7. Azrin MA, Mitchel JF, Fram DB, Pedersen CA, Cartun RW, Barry JJ et al. Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons. Circulation 1994;90:433-41.
8. Chan P, Mill S, Mulloy B, Kakkar V, Demoliou-Mason C. Heparin inhibition of human vascular smooth muscle cell hyperplasia. Int Angiol 1992;11:261-7.
9. Gilbertson JJ, Pettengill OS, Cronenwett JL. Antiproliferative effect of heparin on human smooth muscle cells cultured from intimal hyperplastic lesions of vein grafts. Ann Vasc Surg 1992;6:265-71.
10. Gimple LW, Gertz SD, Haber HL, Ragosta M, Powers ER, Roberts WC et al. Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterolemic rabbits. A quantitative angiographic and histopathological study. Circulation 1992;86:1536-46.
11. Chadda N. Heparin-Bonded VIABAHN Stent-graft for SFA Lesions: incidence of stent thrombosis and heparin-induced thrombocy- topenia. Abstract presented at the TCT 2008: Transcatheter Cardiovascular Therapeutics 20th Annual Scientific Symposium; October 12-17, 2008; Washington, DC. Am J Cardiol 2008;102(Suppl. 1):221i.
12. Cragg AH, Dake MD. Percutaneous femoropopliteal graft placement. Radiology 1993;187:643-8.
13. Rodriguez-Lopez JA, Soler L, Werner A, Martinez E, Papazoglou K, Diethrich EB. Long-term follow-up of endoluminal grafting for aneurysmal and occlusive disease in the superficial femoral artery. J Endovasc Surg 1999;6:270-7.
14. Lammar J, Dake MD, Bleyn J, Katzen BT, Cejna M, Piquet P et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology 2000;217:95-104.
15. Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft. J Endovasc Ther 2003;10:619-28.
16. Hartung O, Otero A, Dubuc M, Boufi M, Barthelemy P, Aissi K et al. Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants. Eur J Vasc Endovasc Surg 2005;30:300-6.
17. Jahnke T, Andresen R, Muller-Hulsbeck S, Schafer FK, Voshage G, Heller M et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol 2003;14:41-51.
18. Fischer M, Schwabe C, Schulte KL. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 2006;13:281-90.
19. Saxon RR, Coffman JM, Gooding JM, Natuzzi E, Ponec DJ. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003;14:303-11.
20. Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008;19: 823-32.
21. McQuade K, Gable D, Hohman S, Pearl G, Theune B. Randomized comparison of ePTFE/nitinol self-expanding stent-graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2009;49:109-15, 116 e1-9; discussion 116.
22. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent-grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007;45:10-6; discussion 16.
23. Eisner M, Auch-Schwelk W, Britten M, Walter DH, Schachinger V, Zeiher AM. Coronary stent-grafts covered by a polytetrafluoroethylene membrane. Am J Cardiol 1999;84:335-8.
24. Saxon RR, Coffman JM, Gooding JM, Ponec DJ. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol 2007;18:1341-9; quiz 1350.
25. Saxon, RR. Edge stenosis after SFA stent-grafting for occlusive disease: what do we know and what can be done to prevent or treat it. Prevention and management. Presented at the VEITH symposium; New York, NY, USA; 19 Nov 2009.
26. Golden MA, Hanson SR, Kirkman TR, Schneider PA, Clowes AW. Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg 1990;11:838-44; discussion 845.
27. Virmani R, Kolodgie FD, Dake MD, Silver JH, Jones RM, Jenkins M et al. Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries. J Vasc Interv Radiol 1999;10:445-56.
28. White R, Kopchok G, Zalewski M, Ayres B, Wilson E, de Virgilio C et al. Comparison of the deployment and healing of thin-walled expanded PTFE stented grafts and covered stents. Ann Vasc Surg 1996;10:336-46.
29. Ariyoshi H, Okuyama M, Okahara K, Kawasaki T, Kambayashi J, Sakon M et al. Expanded polytetrafluoroethylene (ePTFE) vascular graft loses its thrombogenicity six months after implantation. Thromb Res 1997;88:427-33.
30. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5.
31. Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 1984;70:619-23.
32. Alimi YS, Hakam Z, Hartung O, Boufi M, Barthelemy P, Aissi K et al. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency? Eur J Vasc Endovasc Surg 2008;35:346-52.
33. Clark TW, Groffsky JL, Soulen MC. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 2001;12:923-33.
34. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
35. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88.
36. Ansel GM. Interim results of the VIBRANT trial. Presented at Vascular Interventional Advances (VIVA) 2009.
37. Ishii Y, Sakamoto S, Kronengold RT, Virmani R, Rivera EA, Goldman SM et al. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency. J Thorac Cardiovasc Surg 2008;135:1237-45; discussion 1245-6.